GlassScriptPhysician profile
Riaz A Chaudhry
NPI 1992798003
$8,551.90
in general payments reported to CMS, 2019-2025
36 companies · $587 in 2025
The $587 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $881 · 2020: $585 · 2021: $836 · 2022: $1,546 · 2023: $2,241 · 2024: $1,877 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,455 · Education: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,454.97 |
| Education | $248.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,411.70 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,470.29 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Janssen Pharmaceuticals, INC | $614.60 | 2019-2023 | Xarelto |
| Genzyme Corporation | $537.27 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $515.45 | 2022-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $382.32 | 2020-2024 | Opsumit, Uptravi |
| E.R. Squibb & Sons, L.L.C. | $333.69 | 2022-2023 | Camzyos |
| Amgen INC. | $264.86 | 2019-2024 | Tezspire, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $223.27 | 2019-2023 | Spiriva Respimat, Ofev |
| Mylan Specialty L.P. | $184.60 | 2019-2024 | Yupelri |
| Sanofi-Aventis U.S. LLC | $179.98 | 2022-2024 | |
| Pfizer INC. | $167.98 | 2020-2025 | |
| Abbvie INC. | $141.03 | 2022-2023 | Qulipta |
| Novo Nordisk INC | $138.41 | 2023-2024 | Wegovy |
| Baxter Healthcare | $117.86 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $111.08 | 2024-2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $106.92 | 2019-2023 | |
| Grifols USA, LLC | $105.39 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $105.02 | 2020-2024 | |
| Esperion Therapeutics, INC. | $61.70 | 2021-2024 | Nexletol |
| Takeda Pharmaceuticals U.S.A., INC. | $37.94 | 2022-2024 | Glassia |
| Merck Sharp & Dohme LLC | $33.49 | 2019-2024 | Keytruda |
| Insmed, INC. | $32.58 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $30.67 | 2019 | |
| Ani Pharmaceuticals, INC. | $28.93 | 2022 | |
| Harmony Biosciences LLC | $27.14 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $26.36 | 2021 | |
| Verona Pharma, INC. | $22.73 | 2025 | Ohtuvayre |
| Boston Scientific Corporation | $20.56 | 2023 | |
| Electromed, INC. | $19.46 | 2025 | Smartvest |
| Viatris Specialty LLC | $19.31 | 2025 | Yupelri |
| Ucb, INC. | $17.67 | 2019 | |
| Lilly USA, LLC | $17.57 | 2025 | Mounjaro, Zepbound |
| Mallinckrodt Hospital Products INC. | $15.55 | 2022 | |
| Inogen, INC. | $15.53 | 2024 | |
| Genentech USA, INC. | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riaz Chaudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.